Funder
Pfizer, Inc
Memorial Sloan-Kettering Cancer Center, NY
Reference23 articles.
1. Ljungberg B, Bensalah K, Bex A, et al. Guidelines on Renal Cell Carcinoma. European Association of Urology, 2013. Available from: http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LRV2.pdf. Accessed: September 23, 2013.
2. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009
3. National Cancer Institute. Drugs Approved for Kidney (Renal Cell) Cancer. 2013; http://www.cancer.gov/cancertopics/druginfo/kidneycancer. Accessed: August 14, 2013.
4. Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: when is the revolution coming?;Santoni;Curr Cancer Drug Targets,2013
5. Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies;Ravaud;Oncologist,2011
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献